558.31
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive
Thermo Fisher Scientific to Acquire Clario Holdings For $8.875 Billion - citybiz
Thermo Fisher to buy Clario for $8.8bn - Yahoo Finance
Thermo Fisher Scientific to acquire Clario in $8.9B cash deal - Proactive financial news
Argus Research Adjusts Thermo Fisher Scientific Price Target to $610 From $580 - MarketScreener
Thermo Fisher to Acquire Clario for $8.875 Billion - Contract Pharma
Thermo Fisher Scientific, U.S clinical research major, invests ₹160 cr in Bengaluru for antibody research - The Hindu
Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034 - GlobeNewswire Inc.
Thermo Fisher to buy Clario Holdings for $8.88B - Axios
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now - Nasdaq
Thermo Fisher strikes $9.4bn acquisition of Nordic Capital and Astorg-backed Clario - Private Equity Insights
Does Thermo Fisher's 20% Rally Signal More Upside After New Pharma Partnerships? - Yahoo Finance
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters
Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal - Asianet Newsable
Thermo Fisher Scientific Inc. agreed to acquire Clario Holdings, Inc. for $9.4 bilion. - MarketScreener
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - BioSpace
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - The Wall Street Journal
WilmerHale Advises Thermo Fisher Scientific on $9 Billion Acquisition of Clario - WilmerHale
Thermo Fisher Announces Acquisition of Clario Holdings - TipRanks
Media: Thermo Fisher close to USD 10bn acquisition - medwatch.com
Thermo Fisher to Buy Clinical Services Provider Clario for up to $9.4 Billion - US News Money
Thermo Fisher Scientific to acquire Clario Holdings, enabling pharma and biotech customers to accelerate innovation with deeper clinical insights - MarketScreener
PE investor group to sell clinical trial data firm Clario to Thermo Fisher Scientific for $8.9bn - pehub.com
Thermo Fisher Scientific To Acquire Clario Holdings, Enabling Pharma And Biotech Customers To Accelerate Innovation With Deeper Clinical Insights - TradingView
Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru - Medical Dialogues
Research Antibodies Market to Get an Explosive Growth | Thermo - openPR.com
Thermo Fisher Scientific Expands Bengaluru R&D Center with INR 160 Cr Investment - Digital Health News
M&A News: Thermo Fisher (TMO) Nears $10B Clario Takeover to Strengthen Clinical Trial Tech - TipRanks
Thermo Fisher said to eye $10B takeover of clinical trial software firm Clario - Seeking Alpha
Thermo Fisher Scientific to accelerate life science breakthroughs with OpenAI - SelectScience
5 Revealing Analyst Questions From Thermo Fisher’s Q3 Earnings Call - Yahoo! Finance UK
Thermo Fisher Scientific inaugurates expanded R&D centre of excellence in Bengaluru - ETHRWorld.com
14-year-old Combines Origami and Physics to Engineer - GlobeNewswire
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge - The Manila Times
Thermo Fisher nears $10 billion takeover of Clario, FT reports - Reuters
Thermo Fisher nears $10 bln deal to acquire Clario, FT reports - Investing.com
Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports - MarketScreener
Thermo Fisher nears $10 billion takeover of drug trial software maker ClarioFT - MarketScreener
Thermo Fisher strikes up to $9.4bn takeover of drug trial software maker Clario - Financial Times
Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus
Can Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit consensus price targetsOil Prices & Daily Stock Trend Watchlist - Fundação Cultural do Pará
Thermo Fisher Scientific invests ₹160 cr to expand Bengaluru R&D centre - BusinessLine
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM - The Joplin Globe
Thermo Fisher: Measuring Clinical Supply Chain Emissions - Supply Chain Digital Magazine
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $656 From $560, Keeps Overweight Rating - MarketScreener
Thermo Fisher invests Rs 160 crore to expand Bengaluru R&D centre - Moneycontrol
Is Thermo Fisher Scientific’s Stock Rally Justified After Strategic Growth Initiatives in 2025? - simplywall.st
Thermo Fisher Enhances India's Biotechnology Landscape with R&D Expansion - Devdiscourse
Thermo Fisher invests ₹160 crore to expand Bengaluru R&D facility, to create 100 jobs - ET HealthWorld
Thermo Fisher Scientific invests Rs. 160 crore, Bengaluru R&D will create over 100 jobs - Pharmabiz.com
Thermo Fisher Scientific inaugurates expanded R&D Centre of Excellence in Bengaluru - Express Pharma
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 - BioSpace
Published on: 2025-10-27 23:39:59 - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock outperform benchmarksWeekly Gains Report & Risk Managed Investment Strategies - Fundação Cultural do Pará
Will Thermo Fisher Scientific Inc. stock outperform Nasdaq indexMarket Activity Report & Risk Controlled Daily Plans - Fundação Cultural do Pará
Thermo Fisher Scientific invests Rs 160 Cr to advance innovation in antibody research and manufacturing - IndiaMedToday
Price momentum metrics for Thermo Fisher Scientific Inc. explainedCEO Change & Long-Term Capital Growth Strategies - newser.com
Why Thermo Fisher Scientific Inc. stock is a value investor pickChart Signals & Safe Swing Trade Setups - Fundação Cultural do Pará
Why Thermo Fisher Scientific Inc. (TN8) stock remains top ratedJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
OpenAI lands new pharma deals with Thermo Fisher and Lundbeck - FirstWord Pharma
Thermo Fisher Scientific invests Rs 160 Cr+ to expand Bengaluru R&D facility - BioSpectrum India
Thermo Fisher’s Pullback Is Setting Up Its Next Phase of Growth - The Globe and Mail
Thermo Fisher analysis stations target 97% copper recovery - Mining Magazine
Rheometer Market By Leading Key Players, Opportunities - openPR.com
大文字化:
|
ボリューム (24 時間):